Rating date
Jun 25, 2026
46 days ago
IBM Equity Research — OVERWEIGHT — June 2026
Rating date
Jun 25, 2026
46 days ago
Desk view
OW
5D move
—
Awaiting market data
Peer rank
36p
Investment card · IBM
Here is the analysis note for IBM.
Desk rating
OW
Tactical OW · 12M OW
Horizon
Long-term
Confidence
High
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Bias
OVERWEIGHT
Catalysts
Risks
Price context alongside the research narrative.
Full desk note for Jun 25, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
IBM bias
OVERWEIGHT
Horizon
Long-term
IBM key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
IBM catalyst watch
IBM is in a bearish intermediate-term trend — price below the 200-day SMA with deteriorating momentum. The 50-day SMA has acted as support but is itself sloping downward.
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Confidence
High
How the call aged · 5D
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-26T08:37:16.162903+00:00.
5D move
—
2026-06-25 → awaiting
Outcome
Awaiting market data
5D trend
-1.56%
Vol (20D ann.)
+71.00%
vs SPY: -0.91%
Close 258.27 → — (USD, vendor closes)
Publish QC
Pipeline fingerprint 2f45a102687f75c0
Trace ab451c98…
No QC issues recorded.